MDS-23PREVUE001

About this trial

Last updated 8 months ago

Study ID

MDS-23PREVUE001

Status

Not yet recruiting

Type

Observational

Placebo

Accepting

1+ Years

All

Not accepting

Healthy Volunteers

Trial Timing

Started 8 months ago

This post-market study is being conducted to generate safety and performance data on the BD Prevue(TM) II Peripheral Vascular Access System with Cue(TM) Needle Tracking Technology. The data will be utilized to support regional registrations (for example, EU MDR), and document any unforeseen residual risks.

Inclusion Criteria

- Age 1 years, or older

- A patient who is a candidate for an ultrasound-guided peripheral intravenous catheter (midline catheters included) placement procedure using BD PrevueTM II Peripheral Vascular Access System with CueTM Needle Tracking Technology as assessed per their clinician(s)

- Able and willing to provide informed consent or legal authorized representative (LAR) authorized to give consent on behalf of the subject

Exclusion Criteria

- Any patient in whom ultrasound procedure might interfere with medical care or create undue hardship

- Known, or suspected, allergy to materials contained in the BD PrevueTM II Peripheral Vascular Access System with CueTM Needle Tracking Technology or accessories that may come in contact with the patient

- Localized skin, tissue, or other clinical factors that would prevent completion of the ultrasound procedure

- Previous medical history that would prevent completion of the ultrasound procedure

BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study